Symbols

BGLC

BioNexus Gene Lab·NASDAQ

--(--)

6.90 / 10

Outperform

Analyst coverage is absent, but fund‑flow metrics are positive (score 6.9). Small and large investors show net inflows, while overall and block trends are slightly negative. The moderate inflow ratio suggests cautious optimism amid mixed investor sentiment.

Fund Flow Rating

What is the market sentiment for BGLC?

BGLC holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.90/10 (Outperform).